Reuter K L, Baker S P, Krolikowski F J
Department of Radiology, University of Massachusetts Medical Center, Worcester 01655.
AJR Am J Roentgenol. 1992 Feb;158(2):273-8. doi: 10.2214/ajr.158.2.1729780.
To determine risk factors for carcinoma of the breast, we compared women with cancer on screening and diagnostic mammography with those in whom cancer was not detected. For 39 months, medical histories were collected by mammography technologists on 3492 women having routine screenings or diagnostic mammograms at our institution. Potential risk factors of women with biopsy-proved breast cancer were compared with those in women who had normal findings on mammograms or negative biopsy results (control subjects). Of the 3492 women, 49 had biopsy-proved breast cancer. There were 3361 patients in the control group, including those women with normal findings on mammograms (3294) and those with negative biopsy results (67). Eighty-two women had incomplete questionnaires or were lost to follow up. Nearly all of the patients with breast cancer were postmenopausal compared with 68% of the control subjects. The mean length of lactation for breast cancer patients was significantly less than for control subjects: 5.6 vs 7.5 weeks (p = .015). This was true also for the postmenopausal patients: 8.1 vs 6.1 weeks (p = .041). Postmenopausal breast cancer patients had menstruated significantly more years (p = .016) than the postmenopausal control subjects: 34 vs 31 years, although the mean age at menarche was not different. When corrected for age, there was no significant difference in the total duration of menstruation in the postmenopausal cancer patients compared with the postmenopausal control subjects. Postmenopausal breast cancer patients had a significantly greater (p = .021) average body weight than postmenopausal control subjects: 71.7 vs 66.7 kg, although body weight was the same when all patients were considered. Similar results were found when Quetelet's index for obesity (weight in kg/height in cm2) (p = .004) was calculated for postmenopausal patients: 28 for cancer patients and 26 for control subjects. There was no significant difference in height between the cancer patients and control subjects when all patients or just the postmenopausal patients were considered. History of oral contraceptive use was significantly less common among postmenopausal breast cancer patients than among postmenopausal control subjects: 9% vs 20%. Patients with breast cancer had lower parity than the control subjects. In our series of patients, women in whom breast cancer was detected on mammography lactated less, showed no significant difference in years of menstruation when corrected for age, had a greater average body weight, used oral contraceptives less often, and had fewer children than women in whom no cancer was detected on mammography.
为确定乳腺癌的危险因素,我们将筛查及诊断性乳房X光检查中患癌女性与未检测出癌症的女性进行了比较。在39个月的时间里,乳房X光检查技术人员收集了在我们机构进行常规筛查或诊断性乳房X光检查的3492名女性的病史。将经活检证实为乳腺癌的女性的潜在危险因素与乳房X光检查结果正常或活检结果为阴性的女性(对照对象)进行比较。在这3492名女性中,49名经活检证实患有乳腺癌。对照组有3361名患者,包括乳房X光检查结果正常的女性(3294名)和活检结果为阴性的女性(67名)。82名女性的问卷不完整或失访。几乎所有乳腺癌患者均已绝经,而对照组中这一比例为68%。乳腺癌患者的平均哺乳期明显短于对照组:分别为5.6周和7.5周(p = 0.015)。绝经后患者也是如此:分别为8.1周和6.1周(p = 0.041)。绝经后乳腺癌患者的月经年限明显多于绝经后对照对象(p = 0.016):分别为34年和31年,尽管初潮平均年龄无差异。校正年龄后,绝经后癌症患者与绝经后对照对象的月经总时长无显著差异。绝经后乳腺癌患者的平均体重明显高于绝经后对照对象(p = 0.021):分别为71.7千克和66.7千克,不过考虑所有患者时体重相同。为绝经后患者计算肥胖的奎特利指数(体重千克数/身高平方厘米数)时也发现了类似结果(p = 0.004):癌症患者为28,对照对象为26。考虑所有患者或仅考虑绝经后患者时,癌症患者与对照对象的身高均无显著差异。绝经后乳腺癌患者口服避孕药的使用史明显少于绝经后对照对象:分别为9%和20%。乳腺癌患者的产次低于对照对象。在我们的一系列患者中,乳房X光检查检测出乳腺癌的女性哺乳期较短,校正年龄后月经年限无显著差异,平均体重更大,口服避孕药使用频率更低,且子女数少于乳房X光检查未检测出癌症的女性。